INDIQUBE SPACES · Q1 FY27 · THE VERDICT

Revenue Soars, Profit Collapses: The ₹59 Crore Gap That Changed Everything

Indiqube beat revenue guidance by 11 percentage points, but net profit swung from ₹35 crore claimed to ₹23.9 crore loss filed. Management reaffirmed margin guidance despite the miss—a credibility test that hinges on the H1 audit.

Q1 FY27 results INDIQUBEIndiqube Spaces Ltd18 Aug 2026 · 6 min read

Reported Revenue

₹422.7 Cr

+36.7% YoY, beat guidance

Claimed PAT (on call)

₹35 Cr

8% margin, within guidance

Filed PAT (BSE)

-₹23.9 Cr

-5.3% margin, below lower bound

The gap

₹59 Cr swing

Unexplained on call

On the call, management claimed Q1 net profit of ₹35 crore with an 8% margin — right in the middle of their guided 8–10% range. The stock exchange filing told a different story: a loss of ₹23.9 crore, a -5.3% margin, and a ₹59 crore gap that was never explained. Revenue did beat guidance (36.7% growth vs 25–30% expected), but profit collapsed. That tension — growth strong, profitability missed catastrophically — is the quarter.

Where the profit went

The filing shows net profit as a loss of ₹23.9 crore despite ₹422.7 crore in revenue. EBITDA (~₹85 crore, 20% margin) and EBIT (~₹55 crore, 13% margin) align with management's claims, so the collapse is below that line: depreciation, interest (solar debt increased Q1), and tax appear to be the pressure points. The ₹59 crore discrepancy between claimed and filed profit is not reconciled on the call — no mention of consolidation vs standalone, pre-audit adjustments, or one-time items. Management's tone was confident, but the numbers do not reconcile.

Management's claims vs. what holds up

Claim on the call	What holds up	Verdict
Highest ever quarterly revenue of INR428 crores	Revenue filed at ₹422.7 Cr; 1.2% below claimed	Slightly overstated
PAT increased by 91% to INR35 crores; PAT margin 8%	PAT filed as loss of ₹23.9 Cr; margin -5.3%	Contradicted
Revenue growth of 37% YoY	Filed YoY growth 36.7%	Supported
EBITDA increased 34% to ₹87 Cr; 20% margin	~20% margin approximately matches	Supported
EBIT grew to ₹55 Cr; 13% margin	~13% margin approximately matches	Supported
Reaffirmed PAT margin 8–10% range (prior guidance)	Delivered -5.3%; 13.3pp below lower bound	Contradicted

What changed on this call

Formally, nothing. Management reaffirmed all guidance: 2 million sq ft annual area addition, 20% EBITDA margin range, 8–10% PAT margin range. But Q1 result contradicts PAT guidance by 13.3 percentage points, and no recovery plan was articulated. The strategic narrative — VAS uplift (17% of revenue, targeting 19–21%), new center openings (Noida, Hyderabad, Mumbai), solar capex (₹100–120 Cr for 25–30 MW) — remains intact. Execution on area addition is strong: 1.91 million sq ft added Q1, 3.9 million sq ft signed for 12–18 month delivery. Signed pipeline covers nearly 2 years of growth target.

The bull and bear cases

The debate

Bull case: Revenue beat guidance by 11pp (36.7% vs 25–30%), outpacing prior expectations. The signed 3.9M sq ft pipeline and 2M sq ft annual addition target are on track. VAS contribution is scaling (17% of revenue; 19–21% target by year-end), driving higher-margin revenue. Diversification into Noida/Hyderabad/Mumbai de-risks Bangalore concentration (60% of portfolio). Occupancy stable at 86%, renewal rates 90%, attrition negative — customer stickiness is strong. Long-term multi-city, multi-segment thesis is intact. Bear case: Net profit crashed to -₹23.9 Cr vs ₹35 Cr claimed and 8–10% margin guided. The ₹59 Cr discrepancy is unexplained; credibility on profit guidance is shot. Management reaffirmed margin ranges despite the loss, with no recovery path articulated. Capex and cash flow details were deferred to H1 audit — lack of transparency on capital discipline. GCC exposure (52% of revenue, targeting 54–55%) makes Indiqube vulnerable to tech hiring cycles and macro slowdown. Occupancy at 86% leaves limited room for margin expansion if pricing weakens. The honest read: Revenue growth is genuine and ahead of plan. But profitability is structurally compressed, not cyclically dented. The loss despite strong top-line growth suggests margin headwinds (labor inflation, interest on solar debt, depreciation) are outpacing pricing and VAS uplift. Until Indiqube reconciles the PAT discrepancy and charts a credible path to 8–10% margins, this is a Hold — investors buying the growth story need proof of profit recovery, not just area addition.

The bull-bear ledger

Revenue beats guidance by 11pp (36.7% vs 25–30%)
Signed 3.9M sq ft pipeline on track; 2M sq ft annual target
VAS mix expanding (17% → 19–21% target); higher-margin segment
Occupancy stable 86%; renewal rates 90%; negative attrition
Multi-city diversification (Noida, Hyderabad, Mumbai) reduces Bangalore risk
PAT guidance completely missed (-5.3% vs 8–10% guided; 13.3pp miss)
₹59 Cr discrepancy between claimed and filed PAT unexplained
Capex and cash flow details deferred to H1 audit; lack of transparency
GCC exposure (52% revenue) vulnerable to tech hiring slowdown
Occupancy at peak; limited room for margin expansion if pricing weakens

Risks ranked by how much they should concern a holder

PAT collapse vs claimed and guided range

High

Q1 delivered -5.3% margin vs 8–10% guided. ₹59 Cr discrepancy unexplained; credibility on profit guidance is compromised. Recovery path not articulated. Holders need to see path to profitability, not just revenue growth.

GCC concentration and tech hiring cycle

High

52% of revenue from GCC tenants (expected to grow to 54–55%). Tech/BPO hiring is cyclical; macro slowdown in hiring could cascade to occupancy and pricing pressure within 6–9 months.

Supply pipeline delivery risk

Medium

3.9M sq ft signed; 12–18 month delivery. Delays would compress FY27–FY28 RPA ramp and defer margin expansion. Noida large center (top 5 portfolio-wide) critical for FY28 growth narrative.

Capex and cash flow opacity

Medium

CFO deferred Q1 OCF and full-year capex guidance to H1 audit. Solar capex (₹100–120 Cr) debt-funded; rising interest rates could compress IRR. Lack of disclosure limits visibility on capital discipline.

Occupancy plateau

Medium

86% overall occupancy is stable but at the high end of historical range (80–85%). 1–2pp decline would pressure 20% EBITDA margin. New center ramp (52–57% break-even, 9–12mo to 90%) adds near-term drag.

Accounting anomaly / reconciliation risk

Medium

The PAT claim-vs-filed discrepancy (₹35 Cr claimed vs -₹23.9 Cr filed) suggests standalone vs consolidated, pre/post audit, or one-time adjustment not disclosed. H1 audit will reconcile, but credibility gap persists until explained.

How the street is positioned

The stock closed at ₹178 as of 2026-08-17, down 23.28% from its all-time high of ₹232.01. On day 1 after the result announcement, the stock fell 1.54%; by day 3, it was down 3.89%. The muted reaction suggests the market parsed the PAT discrepancy as accounting noise rather than operational deterioration, but the stock's cumulative 23% drawdown from ATH signals that momentum has faded. Trading volume is normal, indicating neither panic selling nor institutional accumulation. Ownership remains stable: FII at 2.16% (down 0.02pp QoQ), DII at 14.35% (down 0.35pp), promoter at 60.11% (steady). The lack of significant selling pressure from domestic institutions suggests they are neither fleeing nor adding aggressively — a neutral stance that mirrors the stock's price action and indicates the street is as confused as management's numbers are unclear.

What to watch next

1 · H1 FY27 audit and PAT reconciliation
Management must explain the ₹59 Cr discrepancy between claimed and filed profit and reconcile standalone vs consolidated, pre-audit adjustments, or one-time items. Full-year capex and cash flow guidance is due. This is the credibility test.
2 · Noida large center ramp (Q2–Q3 FY28 operationalization)
Largest NCR center, top 5 portfolio-wide. Operational timeline and initial occupancy ramp are critical for Indiqube's multi-city growth thesis. Success de-risks Hyderabad and Mumbai expansion.
3 · Q2–Q3 FY27 organic PAT recovery
Can management stabilize margins at 8–10% guided, or is Q1 loss structural? VAS uplift (17% → 19–21%) and occupancy optimization help, but not enough if core workspace margin compresses further. Track adjusted (organic) PAT, not reported.
4 · Tech hiring cycle and GCC demand
Monitor FY27 GCC absorption in Bangalore and growth markets (Hyderabad, NCR, West). Macro slowdown risk is tail; any softness in IT/BPO hiring flows to Indiqube occupancy within 6–9 months. Watch for GCC customer attrition or delayed expansions.

Indiqube Spaces is a market leader in India's flex-space segment with a credible 2M sq ft annual growth target, multi-city diversification, and a VAS expansion that should drive higher margins. Revenue growth of 36.7% is genuine and beats prior guidance. But the quarter's net profit of -₹23.9 Cr vs ₹35 Cr claimed is a 13.3pp margin miss from guided range, and the discrepancy remains unexplained by management. Reaffirming guidance despite the loss signals either confidence in a quick recovery or a credibility problem — the H1 audit will tell.

For holders, the key question is structural: Can Indiqube defend and recover to 8–10% PAT margins as VAS scales and occupancy optimizes? Or is margin compression (labor inflation, interest on solar debt, depreciation) a permanent feature of the new operating model? Until the PAT reconciliation and a detailed recovery path are disclosed, the stock deserves a Hold — growth is intact, but profit visibility is broken. The number to track from here is organic (adjusted) PAT, not reported PAT with accounting noise. A second consecutive quarter of margin miss, with no credible recovery plan, would turn this into a sell.

Informational and educational content only. Not investment advice.